Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

Certification and Notice of Termination of Registration Under Section 12( g ) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15( d ) of the Securities Exchange Act of 1934

Commission File Number 333-152286

GLOBAL PHARM HOLDINGS GROUP, INC.

(Exact name of registrant as specified in its charter)

25/F, New World Center, No. 6009 Yitian Road,

Futian District, Shenzhen City, China, 518026

+86-755-8303 9661

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.01 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)	x
Rule 12g-4(a)(2)	¨
Rule 12h-3(b)(1)(i)	x
Rule 12h-3(b)(1)(ii)	¨
Rule 15d-6	¨

Approximate number of holders of record as of the certification or notice date: 22.

Pursuant to the requirements of the Securities Exchange Act of 1934, Global Pharm Holdings Group, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.